Triclopidine hydrochloride | B1141

Ticlopidine hydrochloride is orally bioavailable drug inhibiting ADP induced platelet aggregation. It is selective P2Y12 receptor antagonist and might be better alternative in the prevention of atherothrombotic stroke.

Ticlopidine hydrochloride is orally bioavailable drug inhibiting ADP induced platelet aggregation. It is selective P2Y12 receptor antagonist and might be better alternative in the prevention of atherothrombotic stroke.

B1141 | Triclopidine hydrochloride DataSheet

Alternate Name/Synonyms: 5-[(2-Chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride

Appearance: White Solid

Formulation: N/A

CAS Number: 53885-35-1

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: HCl

Molecular Formula: C₁₄H₁₄ClNS.HCl

Molecular Weight: 300.25

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO (>30 mg/ml)

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A selective P2Y12 receptor antagonist.

MDL Number: MFCD00079606

PubChem CID: 65335

SMILES: C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl

InChi: 1S/C14H14ClNS.ClH/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14;/h1-4,6,8H,5,7,9-10H2;1H

InChi Key: MTKNGOHFNXIVOS-UHFFFAOYSA-N